WILMINGTON, N.C., Jan. 20, 2014 /PRNewswire/ -- Lenstatin™ LLC announces worldwide introduction of the very first nutritional supplement specifically formulated to support healthy lens metabolism for patients with early cataract formation. Lenstatin contains a Unique Proprietary Antioxidant Blend of micronutrients with anti-cataractogenic activity, the exact formula of which is not reproduced by any other vitamin preparation.
An emerging body of scientific evidence suggests that specific antioxidants have beneficial effects on human lens metabolism as well as anti-cataractogenic activity. In addition, the general public has an increasingly acute interest in wellness and nutraceutical strategies which are based on scientific data and which may have beneficial effects in inhibiting the progression of chronic pre-surgical conditions. Lenstatin is formulated specifically to fulfill the role of targeted nutritional support in patients with early non-surgical cataracts.
According to Scott W. Tunis MD FACS, a Board Certified Ophthalmologist and Fellow of The American College of Surgeons with over 30 years experience performing more than 25,000 cataract operations,
Dr. Tunis states, "Lenstatin should not replace ongoing professional examination, treatment or surgery, maintaining a healthy lifestyle and diet, and avoiding prolonged UV exposure. However in the setting of early cataracts patients should also consider initiating targeted lens health and anti-cataract nutritional support with Lenstatin."
For more information visit www.Lenstatin.com.
About Lenstatin LLC
Founded by Scott W. Tunis MD FACS in 2013 to develop ocular disease specific nutraceuticals. Dr. Tunis is a Board Certified Fellow of The American Academy of Ophthalmology, a Fellow of The American College of Surgeons, a member of The American Society of Cataract and Refractive Surgery, and holder of two United States Patents on eye surgery technology.
SOURCE Lenstatin LLC